The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study 4407G (WJOG4407G).
Kentaro Yamazaki
Honoraria - Chugai Pharma; Yakult Honsha
Michitaka Nagase
Honoraria - Chugai Pharma; Yakult Honsha
Hiroshi Tamagawa
No relevant relationships to disclose
Shinya Ueda
No relevant relationships to disclose
Takao Tamura
No relevant relationships to disclose
Kohei Murata
No relevant relationships to disclose
Takashi Tsuda
No relevant relationships to disclose
Eishi Baba
Research Funding - Chugai Pharma
Masahiro Tsuda
No relevant relationships to disclose
Toshikazu Moriwaki
Honoraria - Chugai Pharma; Yakult Honsha
Taito Esaki
Honoraria - Chugai Pharma; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
Yasushi Tsuji
No relevant relationships to disclose
Kei Muro
Honoraria - Chugai Pharma; Yakult Honsha
Koichi Taira
No relevant relationships to disclose
Tadamichi Denda
Honoraria - Chugai Pharma; Yakult Honsha
Takahiro Tsushima
No relevant relationships to disclose
Masahiko Ando
No relevant relationships to disclose
Satoshi Morita
Honoraria - Chugai Pharma
Narikazu Boku
Honoraria - Chugai Pharma; Daiichi Sankyo; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
Ichinosuke Hyodo
Honoraria - Chugai Pharma; Daiichi Sankyo; Yakult Honsha
Research Funding - Chugai Pharma; Daiichi Sankyo; Yakult Honsha